22+ years advancing clinical development and strategic alliances in pharmaceuticals.
Explore My ExpertiseDesigning and overseeing clinical strategies for oncology and beyond, ensuring regulatory and market success.
Managing global alliances and product launches across 13+ countries for Rx and OTC solutions.
Leading international studies in 40+ countries, specializing in onco-immunology and infectious diseases.
Since 2021, spearheading oncology trials (NSCLC, prostate) and regulatory negotiations as a consultant.
2013-2021, led Phase I-III onco-immunology programs, including dendritic cell vaccines and IL-15 therapies.
2012-2013, coordinated product launches in cardiology and pulmonology across CIS countries.
2005-2011, managed Phase II-III trials, ensuring ICH-GCP compliance across multiple regions.
MD from Moscow State Medical University, with advanced training from Harvard and MIT.
Fluent in English, facilitating global collaboration and communication.
Expertise in NSCLC, prostate, and bladder cancer trials, advancing immunotherapy solutions.
Strategic oversight of cardiovascular drug development and market entry.
Leading neurological research with a focus on innovative treatment protocols.
Have a project or collaboration in mind? Fill out the form to discuss how my expertise can support your goals in clinical development or business strategy.